René Buholzer
René Buholzer is the Director of Interpharma, the Swiss pharmaceutical industry association. He has expressed concerns about the future of the Swiss pharmaceutical sector in light of potential US tariffs, noting that while existing facilities in Switzerland are likely to continue operations, the country may gradually lose its significance as a hub for investment in new drug manufacturing.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 5.00 | 0.09% | +0% | 8,654,622 | 7,940 | $700,000 | 642$ |
| Totals | 1 | 8,654,622 | 7,940 | $700,000 | 642$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
René Buholzer is the head of the Interpharma industry association and commented on the potential US actions regarding drug prices.
5
Switzerland:
René Buholzer, the head of the Interpharma association, describes Trump's announcement as an ultimate wake-up call.
6
Switzerland:
René Buholzer is the managing director of the pharmaceutical association Interpharma.
6
Switzerland:
René Buholzer, managing director of Interpharma, emphasizes the need for a deal that ensures no tariffs on pharmaceutical products.
7
Switzerland:
René Buholzer is the director of Interpharma, expressing concerns about the future of the pharmaceutical industry in Switzerland.
5